Wednesday, May 24, 2023
Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced today a partnership with Applied Radiology, the leading peer reviewed radiology publication in the United States, where they will introduce "Elucirem | The Reveal Image Challenge." The program provides MR imaging professionals with an opportunity to reveal their MR imaging potential and to share their MRI images using Elucirem™ (gadopiclenol) injection. MRI imaging using Elucirem™ and supporting case information can be submitted on a secure image portal at appliedradiology.com/reveal and will be accepted starting in May-Dec 2023.
A winning image will be selected each month by a review committee, including MRI thought leaders and educators, Applied Radiology board members and Guerbet associates. Throughout the challenge, winning images will be featured on the Applied Radiology website and social media platforms. The program will culminate at the Guerbet booth at the annual RSNA (Radiology Society of North America) Annual Conference from November 26-30, 2023, where the Image of the Year will be revealed. In order to participate in the "Elucirem | The Reveal Image Challenge, MRI professionals are encouraged to consider the following criteria when submitting their images: the MRI images should be taken only for the FDA-approved indications for Elucirem and using approved dosing for Elucirem™ as well as Image Assessment (Contrast Resolution, Contrast to Noise Ratio, Spatial Resolution, Artifacts, MR Contrast Protocol, etc.)
"This partnership with Applied Radiology was conceived as we began to see some extraordinary images coming from the radiology community with the use of Elucirem™," said David Hale, Chief Executive Officer at Guerbet. "We are excited to share the Elucirem™ difference by showcasing these images which tell the story about the future of the industry."